Logo
x

Search

Subscribe Now

Provisional Approval

Moderna's Spikevax Receives TGA's Provisional Approval to Treat COVID-19 in Patients Aged 12-17 Years

Moderna's Spikevax Receives TGA's Provisional Approval to Treat COVID-19 in Patients Aged 12-17 Years

  • September 6, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.